Gary Pekoe, Neal Koller
Alphyn Biologics, Inc., United States
Biography
Gary Pekoe, PhD, is currently Chief Scientific Officer of Alphyn Biologics, Inc. Dr. Pekoe earned a PhD in Pharmacological Toxicology from West Virginia University, Morgantown, West Virginia, USA. Among his many accomplishments, Dr. Pekoe led the successful Bactroban® New Drug Application which was the first ever single agent prescription topical product approved by FDA and generated over $1 billion in sales for GSK. Dr. Pekoe has authored numerous scientific publications.
Neal Koller, is currently Chief Executive Officer of Alphyn Biologics, Inc. Mr. Koller earned a Bachelor of Science degree in Biology with secondary emphasis in Chemistry from University of Richmond, Richmond, Virginia, USA. Among his many accomplishments, Mr. Koller has been responsible for multiple therapeutic device and drug development, clinical trial, regulatory approval and or commercialization programs including the technology leading French 5® cardiac catheter line, Angio Seal® Vascular Closure System, Cardioscan® Cardiac Auscultation System and PluroGel® burn and wound products.